← FDA DRUG APPROVALS

FDA ANDA · ANDA071558

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA071558
TYPE
ANDA
ORIGINAL APPROVAL
1987-03-02
LATEST ACTION
1988-04-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 50MG, PERPHENAZINE 4MG · TABLET · ORAL

Approval history

1988-04-18Labeling · Supplement 6AP
1987-03-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →